免责声明: 本站汇总 FDA、ClinicalTrials.gov、PubMed、SEC EDGAR 等官方公开数据,仅供一般参考,不构成医疗建议、诊断、治疗建议或投资建议。

临床试验

TxAccess and Dd-cfDNA for Improved Care of Patients With Delayed Graft Function

NCT:NCT07825688 · NOT_YET_RECRUITING

NCT编号NCT07825688
状态NOT_YET_RECRUITING
开始日期2026-09-15
完成时间2029-06-30
SponsorDuke University (OTHER)
First posted
Last updated

简要摘要

This is a prospective multicenter nonrandomized pragmatic hybrid effectiveness-implementation study to test the effectiveness of TxAccess in improving time to renal recovery and immunologic outcomes in patients with delayed graft function (DGF) and to assess barriers and facilitators to implementation of TxAccess in the post-transplant care period. Research blood will be collected for donor-derived cell-free DNA testing, and patient questionnaires will be administered.

官方来源

在 ClinicalTrials.gov 上查看 →

数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。

↑